Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 14, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc.
| -72.33K |
$26.08 | -$912,960.92 | -28.95% | 177.54K |
Aug 12
| |||||||
Tarsus Pharmaceuticals, Inc.
| 3.35K |
—
|
—
| +2.45% | 139.98K |
Jun 24
| |||||||
Tarsus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Rxsight, Inc.
| 2.55K |
—
|
—
| +10.40% | 27.1K |
Jun 6
| |||||||
Lensar, Inc.
| 22K |
—
|
—
| +4.22% | 543.27K |
May 7
| |||||||
Rxsight, Inc.
| -31.25K |
$49.67 | -$1,403,120.09 | -59.53% | 21.25K |
Feb 1
| |||||||
Rxsight, Inc.
| -670.27K |
—
|
—
| -89.69% | 77.05K |
Aug 17
| |||||||
Tarsus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Tarsus Pharmaceuticals, Inc.
| 2K |
—
|
—
| +1.49% | 136.63K |
Jun 16
| |||||||
Rxsight, Inc.
| 5.73K |
—
|
—
| +35.36% | 21.94K |
Jun 1
| |||||||
Lensar, Inc.
| 9.29K |
—
|
—
| +1.81% | 521.27K |
May 25
| |||||||
Tarsus Pharmaceuticals, Inc.
| -174.36K |
—
|
—
| -61.34% | 109.89K |
May 11
| |||||||
Rxsight, Inc.
| -159.68K |
—
|
—
| -18.70% | 694.12K |
May 11
| |||||||
Tarsus Pharmaceuticals, Inc.
| -163.38K |
—
|
—
| -36.50% | 284.25K |
Mar 15
|
Scheduled
| ||||||
Tarsus Pharmaceuticals, Inc.
| -207.19K |
—
|
—
| -31.64% | 447.63K |
Nov 10
|
Scheduled
| ||||||
Rxsight, Inc.
| -209.46K |
—
|
—
| -19.70% | 853.8K |
Nov 9
| |||||||
Tarsus Pharmaceuticals, Inc.
| -211.83K |
—
|
—
| -24.44% | 654.82K |
Aug 15
|
Scheduled
| ||||||
Rxsight, Inc.
| -209.46K |
—
|
—
| -16.46% | 1.06M |
Aug 10
| |||||||
Tarsus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Rxsight, Inc.
| -248.02K |
—
|
—
| -16.31% | 1.27M |
Jun 8
| |||||||
Rxsight, Inc.
| 126.98K |
—
|
—
| +100.00% | 253.96K |
May 17
| |||||||
Rxsight, Inc.
| 126.98K |
—
|
—
|
∞
| 126.98K |
Mar 15
| |||||||
Rxsight, Inc.
| 10.35K |
—
|
—
| +27.89% | 47.46K |
Jun 2
| |||||||
Lensar, Inc.
| 4.29K |
—
|
—
| +0.84% | 511.98K |
May 25
| |||||||
Rxsight, Inc.
| -375.00K |
—
|
—
| -22.84% | 1.27M |
May 17
| |||||||
Rxsight, Inc.
| -375.00K |
—
|
—
| -18.59% | 1.64M |
Mar 15
| |||||||
Oyster Point Pharma, Inc.
| 6.84K |
—
|
—
| +23.82% | 35.55K |
Jan 5
| |||||||
Oyster Point Pharma, Inc.
| 6.84K |
—
|
—
| +31.26% | 28.71K |
Dec 21
| |||||||
Tarsus Pharmaceuticals, Inc.
| -245.65K |
—
|
—
| -22.09% | 866.65K |
Nov 11
|
Scheduled
| ||||||
Oyster Point Pharma, Inc.
| -550.00K |
$14.84 | -$8,160,736.41 | -40.15% | 820.02K |
Oct 18
|
Scheduled
| ||||||
Rxsight, Inc.
| 2.05M |
$16.00 | $500,000.00 | +34,955.25% | 2.05M |
Aug 3
| |||||||
Rxsight, Inc.
| 5.86K |
—
|
—
|
∞
| 5.86K |
Jul 30
| |||||||
Rxsight, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tarsus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Oyster Point Pharma, Inc.
| 3.47K |
—
|
—
| +52.52% | 10.07K |
Jun 7
| |||||||
Glaukos Corp
| 2.38K |
—
|
—
| +15.43% | 17.82K |
Jun 3
| |||||||
Lensar, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Oyster Point Pharma, Inc.
| 10.94K |
—
|
—
| +100.10% | 21.88K |
May 12
| |||||||
Oyster Point Pharma, Inc.
| 10.93K |
—
|
—
|
∞
| 10.93K |
Mar 26
| |||||||
Oyster Point Pharma, Inc.
| -927.45K |
—
|
—
| -97.08% | 27.94K |
Dec 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.